TY  - GEN
AU  - Fay,J W
AU  - Wingard,J R
AU  - Antin,J H
AU  - Collins,R H
AU  - Piñeiro,L A
AU  - Blazar,B R
AU  - Saral,R
AU  - Bierer,B E
AU  - Przepiorka,D
AU  - Fitzsimmons,W E
AU  - Maher,R M
AU  - Weisdorf,D J
TI  - FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation
SN  - 0006-4971
PY  - 1996///0517
KW  - Adolescent
KW  - Adult
KW  - Biological Availability
KW  - Bone Marrow Transplantation
KW  - adverse effects
KW  - Chemical and Drug Induced Liver Injury
KW  - Disease-Free Survival
KW  - Female
KW  - Graft vs Host Disease
KW  - epidemiology
KW  - Histocompatibility
KW  - Humans
KW  - Immunosuppressive Agents
KW  - administration & dosage
KW  - Incidence
KW  - Kidney Diseases
KW  - chemically induced
KW  - Leukemia
KW  - mortality
KW  - Life Tables
KW  - Male
KW  - Middle Aged
KW  - Myelodysplastic Syndromes
KW  - Nuclear Family
KW  - Parity
KW  - Safety
KW  - Survival Analysis
KW  - Tacrolimus
KW  - Tissue Donors
KW  - Transplantation, Homologous
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
ER  -